PT76595A - Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines - Google Patents

Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines

Info

Publication number
PT76595A
PT76595A PT76595A PT7659583A PT76595A PT 76595 A PT76595 A PT 76595A PT 76595 A PT76595 A PT 76595A PT 7659583 A PT7659583 A PT 7659583A PT 76595 A PT76595 A PT 76595A
Authority
PT
Portugal
Prior art keywords
benzoazacycloalkyl
imidazolidines
spiro
preparation
Prior art date
Application number
PT76595A
Other languages
English (en)
Portuguese (pt)
Other versions
PT76595B (fr
Inventor
Charles Malen
Jean-Louis Peglion
Jacques Duhault
Michelle Boulanger
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of PT76595A publication Critical patent/PT76595A/fr
Publication of PT76595B publication Critical patent/PT76595B/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT76595A 1982-04-27 1983-04-26 Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines PT76595B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8207203A FR2525603A1 (fr) 1982-04-27 1982-04-27 Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
PT76595A true PT76595A (fr) 1983-05-01
PT76595B PT76595B (fr) 1986-01-21

Family

ID=9273425

Family Applications (1)

Application Number Title Priority Date Filing Date
PT76595A PT76595B (fr) 1982-04-27 1983-04-26 Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines

Country Status (22)

Country Link
JP (1) JPS5910584A (fr)
KR (1) KR840004428A (fr)
AT (1) ATA125383A (fr)
AU (1) AU1395383A (fr)
BE (1) BE896572A (fr)
DD (1) DD209833A5 (fr)
DE (1) DE3315106A1 (fr)
DK (1) DK183583A (fr)
ES (1) ES521895A0 (fr)
FR (1) FR2525603A1 (fr)
GB (1) GB2133401B (fr)
GR (1) GR78481B (fr)
IL (1) IL68497A0 (fr)
IT (1) IT1167123B (fr)
LU (1) LU84770A1 (fr)
MA (1) MA19783A1 (fr)
NL (1) NL8301476A (fr)
NO (1) NO831473L (fr)
OA (1) OA07412A (fr)
PT (1) PT76595B (fr)
SE (1) SE8302347L (fr)
ZA (1) ZA832927B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
EP2189448B1 (fr) 2003-06-17 2014-01-29 Arena Pharmaceuticals, Inc. Procédés de séparation de racemates de 3-Benzazepines
CN101792417A (zh) 2003-06-17 2010-08-04 艾尼纳制药公司 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
KR101281919B1 (ko) 2004-12-21 2013-07-03 아레나 파마슈티칼스, 인크. (r)-8-클로로-1-메틸-2,3,4,5-테트라히드로-1h-3-벤즈아제핀 히드로클로라이드의 결정질 형태
PT1833473E (pt) 2004-12-23 2009-12-17 Arena Pharm Inc Composições de modulador de receptor 5ht2c e métodos de utilização
EP2001852A2 (fr) 2006-04-03 2008-12-17 Arena Pharmaceuticals, Inc. Procédés de préparation de 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine et produits intermédiaires associés
CA2670285A1 (fr) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Procedes de preparation de (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine et intermediaires de celle-ci
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス
CN102648170A (zh) 2009-06-18 2012-08-22 艾尼纳制药公司 制备5-ht2c受体激动剂的方法
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
EP2939677A1 (fr) 2010-09-01 2015-11-04 Arena Pharmaceuticals, Inc. Administration de lorcasérine à des individus avec une insuffisance rénale
CN103189360A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的非吸湿性盐
ES2704455T3 (es) 2010-09-01 2019-03-18 Arena Pharm Inc Formas farmacéuticas de liberación modificada de agonistas de 5-HT2C útiles para la gestión del peso
WO2012030938A1 (fr) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Sels de lorcasérine dotés d'acides optiquement actifs
AU2012392187B2 (en) 2012-10-09 2018-07-12 Arena Pharmaceuticals, Inc. Method of weight management

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
ES8405796A1 (es) 1984-06-16
SE8302347L (sv) 1983-10-28
IT1167123B (it) 1987-05-13
ES521895A0 (es) 1984-06-16
GB2133401A (en) 1984-07-25
DK183583D0 (da) 1983-04-26
PT76595B (fr) 1986-01-21
DD209833A5 (de) 1984-05-23
ATA125383A (de) 1986-05-15
KR840004428A (ko) 1984-10-15
LU84770A1 (fr) 1984-11-28
JPS5910584A (ja) 1984-01-20
SE8302347D0 (sv) 1983-04-26
IL68497A0 (en) 1983-07-31
OA07412A (fr) 1984-11-30
NL8301476A (nl) 1983-11-16
ZA832927B (en) 1984-06-27
AU1395383A (en) 1983-11-03
IT8348155A0 (it) 1983-04-26
NO831473L (no) 1983-10-28
FR2525603B1 (fr) 1984-09-14
GB8311508D0 (en) 1983-06-02
DK183583A (da) 1983-10-28
GB2133401B (en) 1985-10-23
BE896572A (fr) 1983-10-26
DE3315106A1 (de) 1983-11-03
GR78481B (fr) 1984-09-27
FR2525603A1 (fr) 1983-10-28
MA19783A1 (fr) 1983-12-31

Similar Documents

Publication Publication Date Title
FR2479187B1 (fr) Procede de preparation de n-octadienol
RO86698A (fr) Procede pour la preparation des (1-piperidinylalkyle)-pyrhimidinone
RO81944A (fr) Procede de preparasiton des imidosulfamides
FR2527615B1 (fr) Procede de preparation du 26,26,26,27,27,27-hexafluoro-1a,25-dihydroxycholesterol
PT76595A (fr) Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines
RO86511A (fr) Procede pour la preparation des beta-lactames
FR2555575B1 (fr) Procede de preparation de 4-alcoxyanilines
RO86646A (fr) Procede pour la preparation des o0ymethers
RO88128A (fr) Procede pour preparer n-phosphanomethylglycine
FR2562070B1 (fr) Procede de preparation de 2-amino-s-triazines
FR2496660B1 (fr) Procede de preparation de n-acylcarnosine
BE889546A (fr) Procede de preparation de n-cyclohexylbenzothiazole-2-sulfenamide
FR2534905B1 (fr) Procede de preparation de phenylcetones
RO88202A (fr) Procede pour la preparation des spiro-3-heteroazolone
FR2550190B1 (fr) Procede de preparation de b-phenylserine
PT74559A (fr) Procede de preparation de trifluoromethylphenyl-tetrahydropyri-dines substituees
FR2528825B1 (fr) Procede de preparation de meta-chlorobenzotrifluorure
FR2527603B1 (fr) Procede catalytique de preparation de thio-bis-phenols
RO81430A (fr) Procede de preparation des azolul siliglycolethers
FR2529889B1 (fr) Procede de preparation des indoles
FR2526021B1 (fr) Procede de preparation de 3-hydroxy-benzodiazepinones
FR2550790B1 (fr) Procede de preparation de la 4-methylionone
FR2493310B1 (fr) Procede de preparation de thymosine a1
FR2526790B1 (fr) Procede de preparation de la o-phenylenediamine
FR2521556B1 (fr) Procede de preparation de 3, 3'-diamino-diphenylsulfones